Recruiting now
-
A Study of JMT203 in Patients With Cancer Cachexia
Phase 2 · randomised · 307 people · 1 site in China · Recruiting now
-
A Phase I-II Study to Test the Safety and Efficacy of PD1 (AB122) and Adenosine Receptor (AB928) Antagonists With Chemotherapy After Short-Course Radiation for Rectal Cancer.
Phase 2 · 43 people · 3 sites in United States · Recruiting now
-
A Study of JNJ-95437446 in Participants With Advanced-Stage Solid Tumors
Phase 1 · 380 people · 10 sites in 3 countries · Recruiting now
-
SBRT + PD-1 Monoclonal Antibody in Unresectable Colorectal Liver Metastases
Phase 3 · 24 people · 1 site in China · Recruiting now
-
Active Surveillance vs Adjuvant Chemoradiotherapy for Locally Resected Intermediate-Risk T1 Rectal Cancer
Not phased · randomised · 480 people · 3 sites in 2 countries · Recruiting now